MedWatch

Bavarian: The clock is ticking for BMS

The first quarter went as expected for Denmark’s Bavarian Nordic. The clinical program with the prostate hope Prostvac will continue in progress. This means that the Danish company will also come closer to more millions from US company Bristol-Meyers Squibb. Meanwhile, the company’s CFO makes a plea to the world concerning the Zika virus.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us free for 14 days

Try a trial subscription for free access to our quality journalism

Frontpage right now

EMA-chef får kritik for "partisk kampagne"

Direktøren for Det Europæiske Lægemiddelagentur beskyldes for at være lidt for smart og have skruet for hårdt på spin-knappen inden afgørelsen om placeringen af agenturet. Men medarbejderne elsker ham.

Skåninge raser over svensk regering i EMA-sag

I det sydlige Sverige er man fortørnede over, at Sverige ikke støttede Danmark bedre i kampen om at få Det Europæiske Lægemiddelagentur til København. Der bliver både brugt ord som kriminelt, svigt og ubegribeligt.

Latest Top picks in English

Related articles